Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
131 - 140 out of 169Page size: 10
  1. 2022
  2. Published

    Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience

    Lindberg, Å., Eskelund, C. W., Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Grønbæk, Kirsten, Geisler, C. H. & Jerkeman, M., 2022, In: Hematological Oncology. 40, 1, p. 23-31

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

    O'Connell, C. L., Baer, M. R., Ørskov, A. D., Saini, S. K., Duong, V. H., Kropf, P., Hansen, J. W., Tsao-Wei, D., Jang, H. S., Emadi, A., Holmberg-Thyden, S., Cowland, J., Brinker, B. T., Horwood, K., Burgos, R., Hostetter, G., Youngblood, B. A., Hadrup, S. R., Issa, J. P., Jones, P. & 3 others, Baylin, S. B., Siddiqi, I. & Grønbæk, Kirsten, 2022, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28, 24, p. 5306-5316 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma

    Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., Niemann, Carsten, Grønbæk, Kirsten, Jerkeman, M. & Ek, S., 2022, In: Cancer Reports. 5, 8 p., e1524.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study

    Lauritsen, T. B., Østgård, L. S. G., Grønbæk, Kirsten, Dalton, Susanne Oksbjerg & Nørgaard, J. M., 2022, In: Hematological Oncology. 40, 5, p. 1056-1066

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The EHA Research Roadmap: Malignant Lymphoid Diseases

    Dreyling, M., André, M., Gökbuget, N., Tilly, H., Jerkeman, M., Gribben, J., Ferreri, A., Morel, P., Stilgenbauer, S., Fox, C., Maria Ribera, J., Zweegman, S., Aurer, I., Bödör, C., Burkhardt, B., Buske, C., Dollores Caballero, M., Campo, E., Chapuy, B., Davies, A. & 34 others, De Leval, L., Doorduijn, J., Federico, M., Gaulard, P., Gay, F., Ghia, P., Grønbæk, Kirsten, Goldschmidt, H., Kersten, M. J., Kiesewetter, B., Landman-Parker, J., Le Gouill, S., Lenz, G., Leppä, S., Lopez-Guillermo, A., Macintyre, E., Mantega, M. V. M., Moreau, P., Moreno, C., Nadel, B., Okosun, J., Owen, R., Pospisilova, S., Pott, C., Robak, T., Spina, M., Stamatopoulos, K., Stary, J., Tarte, K., Tedeschi, A., Thieblemont, C., Trappe, R. U., Trümper, L. H. & Salles, G., 2022, In: HemaSphere. 6, 6, p. E726

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Therapeutic Potential of an Immune-Modulatory Vaccination Targeting Myeloid-Derived Suppressor Cells in Myelodysplastic Syndrome

    Bentivegna, Sofia, Holmstrøm, M., Balhuizen, Alexander, Almosailleakh, M., Perez Penco, Maria, Porse, Bo Torben, Andersen, Mads Hald & Grønbæk, Kirsten, 2022, In: Blood. 140, Suppl. 1, p. 4007-4008 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research

  8. Published

    "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

    Rasmussen, B., Gohring, G., Bernard, E., Nilsson, L., Tobiasson, M., Jadersten, M., Garelius, H., Dybedal, I., Gronbaek, K., Ejerblad, E., Lorenz, F., Flogegard, M., Marcher, C. W., oster Fernstrom, A., Cavelier, L., Papaemmanuil, E., Ebeling, F., Kittang, A. O., Norgaard, J. M., Saft, L. & 2 others, Mollgard, L. & Hellstrom-Lindberg, E., May 2022, In: Leukemia. 36, 5, p. 1436-1439 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. 2023
  10. Published

    10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark

    Lauritsen, T. B., Nørgaard, J. M., Dalton, Susanne Oksbjerg, Grønbæk, Kirsten, El-Galaly, T. C. & Østgård, L. S. G., 2023, In: Leukemia Research. 128, 10 p., 107056.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

    El-Galaly, T. C., Gaidzik, V. I., Gaman, M. A., Antic, D., Okosun, J., Copland, M., Sexl, V., Fielding, A. K., Doeswijk, R., Parker, H., Dreyling, M., Döhner, K., Almeida, A. M., Macintyre, E., Gribben, J. G. & Grønbæk, Kirsten, 2023, In: HemaSphere. 7, 3, 4 p., e842.

    Research output: Contribution to journal › Editorial › Research

  12. Published

    A second update on mapping the human genetic architecture of COVID-19

    Kanai, M., Andrews, S., Cordioli, M., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Pathak, G. A., Ellinghaus, D., Banasik, K., Brunak, S., Pedersen, O. B., Westergaard, D., Sequeros, C. B., Nissen, J., Feldt-Rasmussen, U., Grønbæk, K., Ostrowski, S. R., Guindo-Martinez, M., Garcia, S. M. & 70 others, Hjalgrim, Henrik, Admin team lead, A. T. L., Admin team member, A. T. M., Analysis team lead, A. T. L., Analysis team member, A. T. M., Data collection lead, D. C. L., Data collection member, D. C. M., Manuscript analysis team lead, M. A. T. L., Manuscript analysis team members: Mendelian randomization, M. A. T. M. M. R., Manuscript analysis team members: methods development, M. A. T. M. M. D., Manuscript analysis team members: phenome-wide association study, M. A. T. M. P. A. S., Manuscript analysis team members: principal component projection, gene prioritization, M. A. T. M. P. C. P. G. P., Project management lead, P. M. L., Scientific communication lead, S. C. L., Scientific communication member, S. C. M., Writing group lead, W. G. L., Writing group member, W. G. M., 23andMe, 2., Adolescent brain and cognitive development study, A. B. A. C. D. S., Analysis group, A. G., Armenia_Covid-19hg, A., Assessment of the influence of clinical, functional, immunological and genetic factors on the severity of the course of coronavirus infection with SARS-CoV-2 and post-COVID syndrome, A. O. T. I. O. C. F. I. A. G. F. O. T. S. O. T. C. O. C. I. W. S. A. P. S., Avon Longitudinal Study of Parents and Children (ALSPAC), A. L. S. O. P. A. C. (., BelCovid, B., Biobanque Quebec COVID19, B. Q. C., BioVU, B., Bonn Study of COVID-19 Genetics, B. S. O. C. G., CGEn HostSeq—Canadian COVID-19 Human Host Genome Sequencing Databank, C. H. C. H. H. G. S. D., Colorado Center for Personalized Medicine—CCPM, C. C. F. P. M., COMRI/Virology Study, C. S., Covid19 Ioannina Biobank, C. I. B., COVID19-Host(a)ge, C., Covid19hg-CL, C., Danish COVID-19 Genomic Consortium, D. C. G. C., Egypt hgCOVID hub, E. H. H., EraCORE, E., FinnGen, F., French hgCOVID, F. H., GCAT. Genomes For Life, G. G. F. L., Genes & Health, G. &. H., Genetic influences on severity of COVID-19 illness in Korea, G. I. O. S. O. C. I. I. K., GenOMICC, G., Genotek COVID-19 study, G. C. S., Helix Exome+ COVID-19 Phenotypes, H. E. C. P., Host Genetic Factors for COVID-19 Severity and Outcome in Western Indian Population, H. G. F. F. C. S. A. O. I. W. I. P., Host Genetics in COVID Cohorts of Mixed ancestry from Mexico, H. G. I. C. C. O. M. A. F. M., Japan Coronavirus Taskforce, J. C. T., Japan NCGM-COVID19, J. N., Jordan COVID-19 Host Genomics Initiative (JCHGI), J. C. H. G. I. (., Leadership, L., Lung eQTL Consortium, L. E. C., Mass General Brigham—Host Vulnerability to COVID-19, M. G. B. V. T. C., MexGen-COVID, M., Pa-COVID-19, P., Project management group, P. M. G., Project management support, P. M. S., Qatar Genome Program, Q. G. P., SARS-CoV-2 and Host Genome sequencing, S. A. H. G. S., Scientific communication group, S. C. G., Search for Genomic Markers Predicting the Severity of the response to COVID-19, S. F. G. M. P. T. S. O. T. R. T. C., Spanish COalition to Unlock Research on host GEnetics on COVID-19 (SCOURGE), S. C. T. U. R. O. H. G. O. C. (., The Danish Blood Donor Study, T. D. B. D. S., The Genetic Predisposition to severe COVID-19, T. G. P. T. S. C., Tirschenreuth Study (TiKoco), T. S. (., UCLA Precision Health COVID-19 Host Genomics Biobank, U. P. H. C. H. G. B., UK Biobank, U. B., Variability in Immune Response Genes and Severity of SARS-CoV-2 Infection (INMUNGEN-CoV2 study), V. I. I. R. G. A. S. O. S. I. (. S., Website development, W. D., Writing Group, W. G. & The COVID-19 Host Genetics Initiative, T. C. H. G. I., 2023, In: Nature. 621, 7977, p. E7-E26 23 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

Previous 1...10 11 12 13 14 15 16 17 Next

ID: 37722667